Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.72 USD | +1.10% | -0.18% | -3.31% |
Apr. 25 | Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing | MT |
Apr. 22 | Vaxcyte Insider Sold Shares Worth $490,199, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 6.6B |
---|---|---|---|---|---|
Net income 2024 * | -464M | Net income 2025 * | -509M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-14.3
x | P/E ratio 2025 * |
-13.5
x | Employees | 254 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.4% |
Latest transcript on Vaxcyte, Inc.
1 day | +1.10% | ||
1 week | -0.18% | ||
Current month | -11.11% | ||
1 month | -11.11% | ||
3 months | -5.58% | ||
6 months | +29.19% | ||
Current year | -3.31% |
Managers | Title | Age | Since |
---|---|---|---|
Jeff Fairman
FOU | Founder | 60 | 13-05-26 |
Grant Pickering
FOU | Founder | 56 | 13-05-26 |
Director of Finance/CFO | 55 | 20-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Grant Pickering
FOU | Founder | 56 | 13-05-26 |
Director/Board Member | 58 | 21-09-15 | |
Michael Kamarck
BRD | Director/Board Member | 73 | 21-10-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.27% | 0 M€ | 0.00% | - | |
0.10% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 60.72 | +1.10% | 594,302 |
24-04-25 | 60.06 | -0.40% | 1,566,189 |
24-04-24 | 60.3 | -0.95% | 701,758 |
24-04-23 | 60.88 | -1.17% | 665,981 |
24-04-22 | 61.6 | +1.27% | 627,167 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.31% | 6.6B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PCVX Stock